Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update describes the evaluation of LYNC-101 for injection in healthy adults, focusing on safety, tolerability, pharmacokinetics, pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LYNC-101

Snippet

Sponsor: LyncBio Therapeutics Co., Ltd. | Conditions: UC - Ulcerative Colitis | Phase 1 | Status: NOT_YET_RECRUITING